Status:

COMPLETED

Study of Effects of Sildenafil on Patients With Fontan Heart Circulation

Lead Sponsor:

Medical University of South Carolina

Collaborating Sponsors:

American Heart Association

Conditions:

Single Ventricle Heart Disease After Fontan Surgery

Eligibility:

All Genders

3-40 years

Phase:

PHASE4

Brief Summary

The study will investigate the cardiovascular effects of sildenafil on patients with Fontan circulation. Recent studies suggest that sildenafil may improve exercise in patients with Fontan circulation...

Detailed Description

Modifications to surgical procedures and medical treatment have led to a rapidly declining mortality rates in patients with single-ventricle heart disease (SV). However, SV patients still suffer from ...

Eligibility Criteria

Inclusion

  • Presence of a congenital heart defect that leads to single ventricle physiology
  • Previously performed Fontan surgery

Exclusion

  • The use of phosphodiesterase type 5 (PDE5) inhibitors at the time of catheterization of within 1 month of catheterization
  • Unstable arrhythmia at the time of catheterization
  • History of unstable arrhythmia within 2 months of catheterization
  • Venous, arterial or cardiac malformation that precludes the proper placement of a microconductance catheter
  • Allergy to sildenafil or previous significant adverse reaction to sildenafil (e.g. hypotension)

Key Trial Info

Start Date :

February 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2014

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01815502

Start Date

February 1 2013

End Date

December 1 2014

Last Update

December 7 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University of South Carolina

Charleston, South Carolina, United States, 29425